Brief: Haemonetics Corp Reports Q3 Revenue Of $348.5 Million, Up 3.7% YoY
Feb 6 (Reuters) - Haemonetics Corp HAE.N :
* Q3 REVENUE $348.5 MILLION, UP 3.7% YOY
* Q3 ADJUSTED EPS $1.19
* Q3 EARNINGS PER SHARE VIEW $1.17, REVENUE VIEW $352.9
MILLION --
LSEG IBES DATA
* OUTLOOK FY ADJUSTED EPS $4.50 - $4.70
* OUTLOOK FY REPORTED REVENUE UP 3% - 5%
* FY2025 EARNINGS PER SHARE VIEW $4.59 -- LSEG IBES DATA
Source text: ID:n0000313143-25-000011
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices